ATXI - Avenue Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-1.431M

Cash

3.194M

Avg Qtr Burn

-2.75M

Short % of Float

4.68%

Insider Ownership

1.90%

Institutional Own.

1.99%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
IV Tramadol Details Pain, Post operative acute pain	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
BAER-101 Details Anxiety Disorders, Epilepsy	Phase 2a Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AJ201 Details Spinal and bulbar muscular atrophy , Spinocerebellar Ataxia, Huntington's disease, Kennedy's Disease	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.